Researchers at the University of California San Diego School of Medicine have published the first study to define early-onset cirrhosis caused by metabolic dysfunction-associated steatotic liver disease (MASLD), a condition known as fatty liver disease.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Mouse study identifies bile acid pathways that may reduce liver fat | 0 | 9.19 | 17-09-2026 |
| 2 | Metabolic dysfunction-associated steatotic liver disease linked to higher odds of eosinophilic esophagitis | 0 | 11.82 | 01-08-2026 |
| 3 | Binge drinking just once a month may triple your risk of liver scarring | 0 | 5.08 | 04-04-2026 |
| 4 | Cirrhosis can recur after liver transplant | 0 | 8.75 | 22-09-2026 |
| 5 | Drug candidate treats severe fatty liver disease by protecting the gut in animal models | 2 | 7 | 07-07-2026 |
| 6 | Metabolic improvements cut MASLD-linked colorectal neoplasia risk | 0 | 12.12 | 12-08-2026 |
| 7 | Пензенцам рассказали о неалкогольной жировой болезнь печени: почему возникает и как защитить орган | 0 | 13.96 | 27-07-2026 |
| 8 | Раскрыт неожиданный фактор риска развития жировой болезни печени | 5 | 7 | 30-06-2026 |
| 9 | Appetite-suppressing hormone may protect liver from inflammation through newly discovered signaling pathway | 0 | 7.49 | 10-08-2026 |